Suturing Distance From the Wound Edge, 2 mm vs 5 mm
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03330041 |
Recruitment Status :
Completed
First Posted : November 6, 2017
Results First Posted : January 21, 2020
Last Update Posted : May 12, 2021
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cutaneous Sutures and Scar Cosmesis | Device: Fast absorbing gut suture | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 50 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Intervention Model Description: | At the follow-up visit, two blinded observers will record their scores independently using the physician observer scar assessment score instrument (POSAS). |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Other |
Official Title: | Aesthetic Outcome of Running Cuticular Suture Distance (2mm vs 5mm) From Wound Edge on the Closure of Linear Wounds on the Head and Neck: a Randomized Evaluator Blinded Split Wound Comparative Effective Trial. |
Actual Study Start Date : | October 3, 2017 |
Actual Primary Completion Date : | August 9, 2018 |
Actual Study Completion Date : | August 9, 2018 |

Arm | Intervention/treatment |
---|---|
Experimental: Fast absorbing gut suture placed 2 mm apart
Wound closed with sutures spaced 2 millimeters apart will be treated in a simple, interrupted cutaneous suture pattern
|
Device: Fast absorbing gut suture
Fast absorbing surgical gut suture is a strand of collagenous material |
Experimental: Fast absorbing gut suture placed 5 mm apart
Wound closed with sutures spaced 5 millimeters apart will be treated in a simple, interrupted cutaneous suture pattern
|
Device: Fast absorbing gut suture
Fast absorbing surgical gut suture is a strand of collagenous material |
- Patient Posas Score [ Time Frame: 3 months following procedure ]Scale name: Patient Observer Scar Assessment Score. Scale measures six parameters of scars, each using a 10-point scoring system (the six categories are summed to achieve the POSAS score - totals range from 6 to 60), with 1 representing normal skin & 10 representing the most severe scar imaginable.
- Width of Scar [ Time Frame: 3 months following procedure ]
A secondary endpoint will include the width of the scar 1 cm from midline on each side.
This measurement will be reported in mm
- Erythema [ Time Frame: 3 months following procedure ]If one half of the scar has more associated erythema, this will be noted number of people with erythema after treatment will be reported

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 18 years of age or older
- Able to give informed consent themselves
- Patient scheduled for cutaneous surgical procedure on the trunk and extremities with predicted primary closure
- Willing to return for follow up visit.
Exclusion Criteria:
- Mentally handicapped
- Unable to understand written and oral English
- Incarceration
- Under 18 years of age
- Pregnant Women
- Wounds with predicted closure length less than 4 cm

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03330041
United States, California | |
University of California, Davis, Department of Dermatology | |
Sacramento, California, United States, 95816 |
Principal Investigator: | Daniel Eisen, M.D. | University of California, Davis |
Documents provided by University of California, Davis:
Responsible Party: | University of California, Davis |
ClinicalTrials.gov Identifier: | NCT03330041 |
Other Study ID Numbers: |
1115596 |
First Posted: | November 6, 2017 Key Record Dates |
Results First Posted: | January 21, 2020 |
Last Update Posted: | May 12, 2021 |
Last Verified: | April 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Cutaneous Sutures Scar Cosmesis Linear Wound Closure Wound Cosmesis |
Wounds and Injuries |